Jerusalem
Israel
6
2025-08-28
4
2023-11-14
These are the the leading inventors for applications assigned to IMMUNE SYSTEM KEY LTD.:
IMMUNE SYSTEM KEY LTD. based in Jerusalem, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
BCL2 INHIBITOR AND PEPTIDE COMBINATION THERAPY FOR TREATING PROLIFERATIVE DISEASES
#2 | 2021-05-27 ✅ Patent 11,813,305 granted on 2023-11-14Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancer
#3 | 2018-11-22 ✅ Patent 10,933,117 granted on 2021-03-02Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancer
#4 | 2016-10-20 ✅ Patent 9,878,015 granted on 2018-01-30Pharmaceutical compositions and methods for the treatment of metastatic cancer
#5 | 2010-08-12THERAPEUTIC METHODS USING A THYMUS PEPTIDE
#6 | 2009-01-15 ✅ Patent 8,071,716 granted on 2011-12-06Thymus-specific protein
Also check out IMMUNE SYSTEM KEY LTD.'s (Jerusalem, Israel) applicant profile with 4 patent applications submitted.
141958 ⎘